UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

First-in-human study of BLU-554, a potent, highly-selective FGFR4 inhibitor designed for hepatocellular carcinoma (HCC) with FGFR4 pathway activation

Kim, R; Sharma, S; Meyer, T; Sarker, D; Macarulla, T; Sung, M; Choo, SP; ... Llovet, JM; + view all (2016) First-in-human study of BLU-554, a potent, highly-selective FGFR4 inhibitor designed for hepatocellular carcinoma (HCC) with FGFR4 pathway activation. Presented at: 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Munich, GERMANY.

Full text not available from this repository.
Type: Conference item (UNSPECIFIED)
Title: First-in-human study of BLU-554, a potent, highly-selective FGFR4 inhibitor designed for hepatocellular carcinoma (HCC) with FGFR4 pathway activation
Event: 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Location: Munich, GERMANY
Dates: 29 November 2016 - 02 December 2016
DOI: 10.1016/S0959-8049(16)32704-6
Keywords: Science & Technology, Life Sciences & Biomedicine, Oncology
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: http://discovery.ucl.ac.uk/id/eprint/1535954
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item